Its designed for long-term use, but people who take semaglutide may experience weight gain if they stop taking the medication
By imitating a natural hormone, Semaglutide supports your weight loss efforts
The pharmacodynamic evaluations described below were in patients with type 2 diabetes mellitus who received once-weekly subcutaneous injections of placebo or semaglutide injection over 12 weeks (semaglutide injection-treated patients were started on lower dosages and then titrated up to 1 mg once weekly)
Acne is not listed among the recognised adverse effects in the UK SmPC for Mounjaro, nor has it been identified as a significant concern in the pivotal SURPASS clinical trial programme for diabetes or the SURMOUNT programme for weight management that supported the medication's regulatory approval
The FDA and the EMA are currently evaluating the approval of semaglutide based on results from the SUSTAIN trial, which recruited over 8,000 patients with type 2 diabetes
Two clients both at the same starting weight